Profile | GDS5420 / 40837_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 296.74 | 59 |
GSM1296119 | B_lesional_pre-dose | 413.39 | 65 |
GSM1296076 | C_lesional_pre-dose | 194.97 | 54 |
GSM1296092 | D_lesional_pre-dose | 364.06 | 63 |
GSM1296103 | E_lesional_pre-dose | 280.93 | 58 |
GSM1296078 | F_lesional_pre-dose | 208.69 | 55 |
GSM1296107 | G_lesional_pre-dose | 325.96 | 60 |
GSM1296109 | H_lesional_pre-dose | 377.72 | 62 |
GSM1296080 | I_lesional_pre-dose | 549.51 | 69 |
GSM1296090 | J_lesional_pre-dose | 355.85 | 63 |
GSM1296074 | K_lesional_pre-dose | 174.16 | 52 |
GSM1296111 | L_lesional_pre-dose | 213.9 | 53 |
GSM1296099 | M_lesional_pre-dose | 553.56 | 69 |
GSM1296086 | O_lesional_pre-dose | 401.3 | 65 |
GSM1296117 | P_lesional_pre-dose | 264.83 | 56 |
GSM1296113 | Q_lesional_pre-dose | 324.28 | 59 |
GSM1296096 | R_lesional_pre-dose | 431.32 | 65 |
GSM1296105 | S_lesional_pre-dose | 801.07 | 75 |
GSM1296098 | T_lesional_pre-dose | 499.7 | 67 |
GSM1296101 | U_lesional_pre-dose | 472.57 | 66 |
GSM1296121 | V_lesional_pre-dose | 314.98 | 60 |
GSM1296088 | W_lesional_pre-dose | 434.59 | 65 |
GSM1296082 | X_lesional_pre-dose | 251.7 | 58 |
GSM1296115 | Y_lesional_pre-dose | 264.29 | 57 |
GSM1296084 | Z_lesional_pre-dose | 579.01 | 70 |
GSM1296072 | B_lesional_day8 | 592.56 | 71 |
GSM1296069 | L_lesional_day8 | 307.49 | 58 |
GSM1296071 | P_lesional_day8 | 657.29 | 72 |
GSM1296070 | Y_lesional_day8 | 367.51 | 62 |
GSM1296073 | V_lesional_day8 | 197.06 | 53 |
GSM1296034 | A_lesional_day15 | 1063.25 | 80 |
GSM1296041 | G_lesional_day15 | 143.54 | 46 |
GSM1296035 | R_lesional_day15 | 584.63 | 70 |
GSM1296038 | U_lesional_day15 | 437.43 | 65 |
GSM1296047 | B_lesional_day15 | 650.31 | 72 |
GSM1296039 | E_lesional_day15 | 182.01 | 51 |
GSM1296042 | H_lesional_day15 | 279.4 | 57 |
GSM1296043 | L_lesional_day15 | 396.43 | 63 |
GSM1296037 | M_lesional_day15 | 1659.84 | 87 |
GSM1296046 | P_lesional_day15 | 447.17 | 65 |
GSM1296044 | Q_lesional_day15 | 525.26 | 68 |
GSM1296045 | Y_lesional_day15 | 440.16 | 65 |
GSM1296025 | C_lesional_day15 | 756.92 | 74 |
GSM1296033 | D_lesional_day15 | 703.46 | 73 |
GSM1296027 | I_lesional_day15 | 1091.96 | 80 |
GSM1296032 | J_lesional_day15 | 1131.61 | 81 |
GSM1296024 | K_lesional_day15 | 867.14 | 77 |
GSM1296031 | W_lesional_day15 | 974.59 | 79 |
GSM1296028 | X_lesional_day15 | 959.42 | 78 |
GSM1296029 | Z_lesional_day15 | 924.48 | 77 |
GSM1296026 | F_lesional_day15 | 401.5 | 65 |
GSM1296030 | O_lesional_day15 | 581.58 | 70 |
GSM1296040 | S_lesional_day15 | 887.96 | 77 |
GSM1296036 | T_lesional_day15 | 439.1 | 65 |
GSM1296048 | V_lesional_day15 | 351.96 | 62 |
GSM1296059 | A_lesional_day43 | 562.04 | 70 |
GSM1296066 | G_lesional_day43 | 227.41 | 54 |
GSM1296060 | R_lesional_day43 | 532.65 | 69 |
GSM1296063 | U_lesional_day43 | 321.7 | 60 |
GSM1296064 | E_lesional_day43 | 207.62 | 54 |
GSM1296067 | H_lesional_day43 | 737.73 | 74 |
GSM1296062 | M_lesional_day43 | 914.69 | 77 |
GSM1296068 | Q_lesional_day43 | 631.37 | 71 |
GSM1296050 | C_lesional_day43 | 721.92 | 74 |
GSM1296057 | D_lesional_day43 | 1160.07 | 81 |
GSM1296052 | I_lesional_day43 | 1031.31 | 79 |
GSM1296054 | J_lesional_day43 | 910.55 | 77 |
GSM1296049 | K_lesional_day43 | 659.19 | 72 |
GSM1296055 | W_lesional_day43 | 880.15 | 77 |
GSM1296053 | X_lesional_day43 | 908.99 | 77 |
GSM1296058 | Z_lesional_day43 | 1007.23 | 79 |
GSM1296051 | F_lesional_day43 | 447.58 | 66 |
GSM1296056 | O_lesional_day43 | 379.47 | 64 |
GSM1296065 | S_lesional_day43 | 629.55 | 71 |
GSM1296061 | T_lesional_day43 | 417.13 | 64 |
GSM1296095 | A_non-lesional_pre-dose | 433.49 | 66 |
GSM1296120 | B_non-lesional_pre-dose | 599.48 | 71 |
GSM1296077 | C_non-lesional_pre-dose | 681.7 | 73 |
GSM1296093 | D_non-lesional_pre-dose | 1239.44 | 83 |
GSM1296104 | E_non-lesional_pre-dose | 442.47 | 66 |
GSM1296079 | F_non-lesional_pre-dose | 752.52 | 74 |
GSM1296108 | G_non-lesional_pre-dose | 483.8 | 67 |
GSM1296110 | H_non-lesional_pre-dose | 587.88 | 70 |
GSM1296081 | I_non-lesional_pre-dose | 1679.28 | 86 |
GSM1296091 | J_non-lesional_pre-dose | 954.62 | 78 |
GSM1296075 | K_non-lesional_pre-dose | 471.85 | 68 |
GSM1296112 | L_non-lesional_pre-dose | 532.89 | 68 |
GSM1296100 | M_non-lesional_pre-dose | 2039.46 | 90 |
GSM1296087 | O_non-lesional_pre-dose | 828.08 | 76 |
GSM1296118 | P_non-lesional_pre-dose | 932.3 | 78 |
GSM1296114 | Q_non-lesional_pre-dose | 534.4 | 69 |
GSM1296097 | R_non-lesional_pre-dose | 732 | 74 |
GSM1296106 | S_non-lesional_pre-dose | 818.05 | 76 |
GSM1296102 | U_non-lesional_pre-dose | 669.17 | 72 |
GSM1296122 | V_non-lesional_pre-dose | 666.64 | 72 |
GSM1296089 | W_non-lesional_pre-dose | 1077.98 | 80 |
GSM1296083 | X_non-lesional_pre-dose | 1365.69 | 84 |
GSM1296116 | Y_non-lesional_pre-dose | 509.61 | 68 |
GSM1296085 | Z_non-lesional_pre-dose | 1361.48 | 84 |